Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, T-cell and B-cell Immunology, Reproductive System and Pregnancy, and CAR-T cell therapy research.
Fusobacterium nucleatum subsp. nucleatum RadD binds Siglec-7 and inhibits NK cell-mediated cancer cell killing
Pregnancy trained decidual NK cells protect pregnancies from harmful Fusobacterium nucleatum infection
Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3
Studying TIGIT activity against tumors through the generation of knockout mice
Identification and characterization of the anti-viral interferon lambda 3 as direct target of the Epstein-Barr virus microRNA-BART7-3p
2B4: A potential target in <i>Staphylococcus aureus</i> associated allergic inflammation
Eradication of CD48-positive tumors by selectively enhanced YTS cells harnessing the lncRNA NeST
<i>Fusobacterium nucleatum</i> and cancer
Placental colonization by Fusobacterium nucleatum is mediated by binding of the Fap2 lectin to placentally displayed Gal-GalNAc
Role of HLA-G in Viral Infections
Candida albicans evades NK cell elimination via binding of Agglutinin-Like Sequence proteins to the checkpoint receptor TIGIT
High mannose level in bladder cancer enhances type 1 fimbria–mediated attachment of uropathogenic E. coli
Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells
P842: NOVEL MULTIFUNCTIONAL TETRAVALENT CD38 NKP46 FLEX-NK ENGAGERS ACTIVELY TARGET AND KILL MULTIPLE MYELOMA CELLS
Novel approach to identify putative Epstein–Barr–virus microRNAs regulating host cell genes with relevance in tumor biology and immunology
Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
Fusobacterium nucleatum CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection
A slowly cleaved viral signal peptide acts as a protein-integral immune evasion domain
The human cytomegalovirus protein UL147A downregulates the most prevalent MICA allele: MICA*008, to evade NK cell-mediated killing
The inhibitory receptor CD300a is essential for neutrophil‐mediated clearance of urinary tract infection in mice
CEACAM1 Activation by CbpF-Expressing E. coli
The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune Recognition
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System
Immunorthodontics: in vivo gene expression of orthodontic tooth movement
Molecular mechanisms of human herpes viruses inferring with host immune surveillance
Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells
Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion
A Unique Regulation Region in the 3′ UTR of HLA-G with a Promising Potential